A61K 49/0043
Fluorescein, used in vivo
Official title: {Fluorescein, used in vivo}
A61K49/0043 (Fluorescein, used in vivo) appears on 459 US grants and 731 published applications in this corpus.
Search patents in A61K- Granted patents
- 459
- Published applications
- 731
- Assignees
- 377
- Inventors
- 1,477
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 3 | 0 |
| 1990 | 1 | 0 |
| 1991 | 3 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 9 | 0 |
| 1999 | 6 | 0 |
| 2000 | 3 | 0 |
| 2001 | 13 | 3 |
| 2002 | 9 | 13 |
| 2003 | 6 | 16 |
| 2004 | 5 | 17 |
| 2005 | 6 | 20 |
| 2006 | 7 | 17 |
| 2007 | 5 | 30 |
| 2008 | 6 | 19 |
| 2009 | 7 | 39 |
| 2010 | 8 | 37 |
| 2011 | 18 | 44 |
| 2012 | 26 | 24 |
| 2013 | 24 | 35 |
| 2014 | 24 | 32 |
| 2015 | 27 | 23 |
| 2016 | 20 | 23 |
| 2017 | 24 | 53 |
| 2018 | 14 | 38 |
| 2019 | 27 | 30 |
| 2020 | 28 | 44 |
| 2021 | 23 | 47 |
| 2022 | 31 | 35 |
| 2023 | 19 | 31 |
| 2024 | 16 | 27 |
| 2025 | 20 | 20 |
| 2026 | 9 | 14 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Detection of colonic neoplasia in vivo using near-infrared peptide targeted against overexpressed cMet4 Aug 2026US 12,697,402 B2The Regents of the University of Michigan
- Methods of applying preparations of dyes and hydrogels to a tissue26 May 2026US 12,636,383 B2
- Rejuvenation of CAR T cell12 May 2026US 12,622,973 B2Purdue Research Foundation
- Bioorthogonal compositions28 Apr 2026US 12,611,461 B2Tambo, Inc.
- Fluorescent contrast agent with targeting function, and preparation method and use thereof17 Mar 2026US 12,576,163 B2Ordos Clinical Medical College of Inner Mongolia. Medical University
- Synthetic estrogen receptor (er)-derived peptide17 Sep 2026US 2026/0274922 A1The Texas A&M University System
- Bi-specific adapters and their use with universal car-t cells in the treatment of caix-expressing tumors10 Sep 2026US 2026/0263643 A1Purdue Research Foundation
- Fluorescein formulations and kits20 Aug 2026US 2026/0241042 A1Opus Life Sciences, LLC
- Carrier Peptide Fragment and Use Thereof20 Aug 2026US 2026/0241043 A1Toagosei Co., Ltd.
- Ophthalmic composition for ocular surgery preparation in patients with ocular surface disease13 Aug 2026US 2026/0232757 A1
Most cited
By later US patents
- Method and device for detecting and quantifying glucose in body fluids905US 5,342,789 ASensor Technologies, Inc. · 1994
- System for selective release of liposome encapsulated material via laser radiation291US 4,891,043 AThe Board of Trustees of the University of Illinois · 1990
- Compositions and methods for analyte detection268US 6,485,703 B1The General Hospital Corporation · 2002
- Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors228US 6,261,537 B1Nycomed Imaging AS · 2001
- Modified PF4 compositions and methods of use156US 5,112,946 ARepligen Corporation · 1992